School of Medicine


Showing 1-20 of 38 Results

  • Maryam Amirahmadi

    Maryam Amirahmadi

    Postdoctoral Scholar, Cardiovascular Medicine

    BioDr. Maryam Amirahmadi is a microsurgery expert and postdoctoral research fellow at Stanford Cardiovascular Institute. She obtained her Doctor of Medicine (MD) degree from Hamadan University of Medical Sciences. After more than a year of experience as a Family and Emergency Physician, she spent around 4 years at the Department of Cardiovascular Surgery of Shiraz University of Medical Sciences where she served as a pediatric and adult Cardiac Intensive Care physician and received training in cardiovascular surgery at Namazi and Faghihi hospitals. She then spent a year in the Department of Vascular Surgery at the University of Miami, Miller School of Medicine, serving as a postdoctoral researcher and performing microsurgery on animals, with her research focused on therapeutic strategies to improve neovascularization after limb ischemia. Dr. Amirahmadi joined Stanford Cardiovascular Institute in 2022 where she is now a postdoctoral research fellow under the supervision of Prof. Philip S. Tsao, a renowned cardiovascular scientist. Her research interests and practical expertise include Microsurgery, and the effect of e-cigarette vaping on factors of inflammatory or immune pathways that can subsequently be related to the molecular mechanisms involved in angiogenesis and arteriogenesis in the murine model of hindlimb ischemia, as well as the mechanisms of e-cigarette and nicotine’s effects in augmenting Abdominal Aortic Aneurysm (AAA) in rodent models of aortic aneurysm, including porcine pancreatic elastase-induced AAA. Dr. Maryam Amirahmadi and her colleagues are currently investigating the transgenerational effects of vaping/nicotine on abdominal aortic aneurysm (AAA) risk.

  • Zahra Azizi

    Zahra Azizi

    Postdoctoral Scholar, Cardiovascular Medicine

    BioI am a medical doctor and clinical epidemiologist, presently serving as a scientist at Stanford University. My work centers on precision medicine, employing digital health, computer science, and artificial intelligence (AI) techniques. I am dedicated to integrating and applying these methodologies within the medical field to generate novel insights and deepen understanding of health-related issues. My focus also extends to tackling health disparities, with the ultimate goal of enhancing patient care and reducing disease impact.

  • Adrian Matias Bacong

    Adrian Matias Bacong

    Postdoctoral Scholar, Cardiovascular Medicine

    Current Research and Scholarly InterestsAdrian M. Bacong, PhD, MPH is a social epidemiologist by training. His research seeks to identify social and structural factors that underlie health inequities by race, ethnicity, and immigration status. Specifically, his work has explored the role of socioeconomic factors in explaining health disparities by immigrant legal status and visa type. Furthermore, Adrian is interested in the effects of immigration on health. He received a NIH F31 award (1F31MD015931-01A1) to examine factors affecting the health of Filipino migrants to the U.S. compared to Filipinos remaining in the Philippines.

    Adrian has also examined the intersections of race, ethnicity, and immigration status among older adults. Finally, Adrian written upon the role of data disaggregation as a method of public health critical race praxis. Currently, Adrian is researching the role of social and policy level factors underlying health disparities among immigrants.

  • Ming Li (Estella) Chen

    Ming Li (Estella) Chen

    Postdoctoral Scholar, Cardiovascular Medicine

    BioI am an MD from Chung Shan Medical University, Taiwan. Before coming to Stanford, I obtained my MS degree in epidemiology at Harvard T.H. Chan School of Public Health, Boston, MA, where I completed graduate training in clinical, pharmacologic, and genetic epidemiology, and pursued advanced skills in biostatistics and causal inference.

    My past research focused on real-world epidemiology studies using patient registries and national health insurance databases to elucidate the predictors or risk factors of immunologic diseases. For my graduate study, I conducted pharmacoepidemiology studies using electronic health record (EHR) data to elucidate the predictors of anti-drug antibodies development and its correlation to autoimmunity, to identify the generation of immunogenicity that may impact the effectiveness of monoclonal antibody therapies in individuals with autoimmune diseases. I gained experience in genetic data manipulation to investigate polymorphisms in response to monoclonal antibody therapies in asthma patients.

    At Stanford, I am involved in research on the identification of molecular determinants of cardiometabolic diseases.

  • Joshua Gillard

    Joshua Gillard

    Postdoctoral Scholar, Cardiovascular Medicine

    BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, proteomics data) derived from human observational or intervention studies (vaccination and experimental human infection) in order to discover molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is focused on the use of deep learning and transformer models to identify novel splice isoforms of hypertrophic cardiomyopathy using whole genome sequencing data.

  • Sneha Goenka

    Sneha Goenka

    Postdoctoral Scholar, Cardiovascular Medicine
    Ph.D. Student in Electrical Engineering, admitted Autumn 2017
    Stanford Student Employee, Hoover Institution

    BioSneha Goenka is a Ph.D. candidate in the Electrical Engineering Department at Stanford University where she is advised by Prof. Mark Horowitz. Her research centers on designing efficient computer systems for advancing genomic pipelines for clinical and research applications, with a focus on improving speed and cost. She is a 2023 Forbes 30 Under 30 Honoree in the Science category, 2022 NVIDIA Graduate Fellow, and 2021 Cadence Women in Technology Scholar. She has a B.Tech. and M.Tech. (Microelectronics) in Electrical Engineering from the Indian Institute of Technology, Bombay where she received the Akshay Dhoke Memorial Award for the most outstanding student in the program.

  • Bruna Filipa Gomes Botelho Quintas

    Bruna Filipa Gomes Botelho Quintas

    Postdoctoral Scholar, Cardiovascular Medicine

    Current Research and Scholarly InterestsThe increasing availability of very large datasets, along with recent advances in deep learning based tools for automatic extraction of cardiac traits, has led to the discovery of further common variants associated with cardiac disease. However, the genetic underpinnings of valvular heart disease remains understudied. I am interested in developing deep learning techniques to automatically extract cardiac flow information to facilitate genome-wide association studies of cardiac flow traits.

  • Hiroyuki Inoue

    Hiroyuki Inoue

    Postdoctoral Scholar, Cardiovascular Medicine

    BioDr. Inoue is a physician-scientist who is enthusiastic about bridging research findings and clinical practice.
    - a board certified cardiologist with 10+ years clinical experience
    - experience in 400+ cases as a main operator in percutaneous coronary intervention, catheter ablation, and cardiac device implantation
    - research expertise primarily in iPSCs, genome editing, and regenerative medicine

    Dr. Inoue joined the Yang lab in 2022. His research aim is the development of novel regenerative therapeutics for heart failure.

  • Pik Fang Kho

    Pik Fang Kho

    Postdoctoral Scholar, Cardiovascular Medicine

    BioI obtained my PhD in genetic epidemiology at Queensland University of Technology (Australia), where my research was focused on using genetic and genomic approaches to identify risk factors for endometrial cancer. During my graduate studies, I gained experience in large-scale genetic association studies and leveraging the correlation between diseases in genetic studies to identify novel genetic variants associated with endometrial cancer. I also developed expertise in various statistical genetic approaches in multi-omics data, including fine-mapping and colocalization analyses, to prioritize candidate causal variants and genes. I also gained extensive experience in genetic causal inference analysis to infer causality between risk factors and health outcomes.

    My research focus since moving to Stanford has been the identification of genetic and non-genetic determinants of cardiometabolic diseases. I am currently involved in projects including large-scale genetic association studies, multi-trait analysis with correlated traits, development and validation of polygenic risk scores, integrative analyses with multi-omics data, as well as Mendelian randomization analyses to advance our understanding of the genetic and environmental factors that contribute to cardiometabolic diseases.